Cargando…

Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver

Liver inflammation is a common feature of chronic liver disease and is often associated with increased exposure of the liver to lipopolysaccharide (LPS). Kupffer cells (KCs) are macrophages in the liver and produce various cytokines. Activation of KCs through the NLRP3 inflammasome pathway leads to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Hye-Young, Lee, So-Hee, Park, Ji Yeon, Han, Eugene, Han, Sol, Hwang, Jae Seok, Kim, Mi Kyung, Jang, Byoung Kuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449201/ https://www.ncbi.nlm.nih.gov/pubmed/37616215 http://dx.doi.org/10.1371/journal.pone.0290532

Ejemplares similares

Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells
por: Seo, Hye-Young, et al.
Publicado: (2022)

Increased Levels of Phosphorylated ERK Induce CTGF Expression in Autophagy-Deficient Mouse Hepatocytes
por: Seo, Hye-Young, et al.
Publicado: (2022)

Kahweol Ameliorates the Liver Inflammation through the Inhibition of NF-κB and STAT3 Activation in Primary Kupffer Cells and Primary Hepatocytes
por: Seo, Hye-Young, et al.
Publicado: (2018)

Loganin Prevents Hepatic Steatosis by Blocking NLRP3 Inflammasome Activation
por: Jang, Joo Hyeon, et al.
Publicado: (2023)

Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
por: Seok, Jin Kyung, et al.
Publicado: (2021)

Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
por: Kim, Kyoung Min, et al.
Publicado: (2017)

Loganin Alleviates Gout Inflammation by Suppressing NLRP3 Inflammasome Activation and Mitochondrial Damage
por: Choi, Nuri, et al.
Publicado: (2021)

Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
por: Seok, Jin Kyung, et al.
Publicado: (2021)

Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome
por: Yang, Gabsik, et al.
Publicado: (2020)

Sinapic Acid Controls Inflammation by Suppressing NLRP3 Inflammasome Activation
por: Lee, Eun Hye, et al.
Publicado: (2021)

Teuvincenone F Suppresses LPS-Induced Inflammation and NLRP3 Inflammasome Activation by Attenuating NEMO Ubiquitination
por: Zhao, Xibao, et al.
Publicado: (2017)

Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ
por: Jang, Jun Young, et al.
Publicado: (2018)

Kahweol activates the Nrf2/HO-1 pathway by decreasing Keap1 expression independently of p62 and autophagy pathways
por: Seo, Hye-Young, et al.
Publicado: (2020)

A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus
por: Kim, Bo-Yeon, et al.
Publicado: (2022)

Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome
por: Yang, Gabsik, et al.
Publicado: (2020)

Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
por: Seo, Da Hea, et al.
Publicado: (2022)

Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
por: Choung, Sorim, et al.
Publicado: (2018)

Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
por: Su, Chia-Cheng, et al.
Publicado: (2021)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
por: Han, Eugene, et al.
Publicado: (2021)

Exogenous 8-Hydroxydeoxyguanosine Attenuates PM(2.5)-Induced Inflammation in Human Bronchial Epithelial Cells by Decreasing NLRP3 Inflammasome Activation
por: Bang, Jihye, et al.
Publicado: (2023)

Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
por: Chang, Yu-Wei, et al.
Publicado: (2021)

Lobeglitazone Attenuates Airway Inflammation and Mucus Hypersecretion in a Murine Model of Ovalbumin-Induced Asthma
por: Shin, Na-Rae, et al.
Publicado: (2018)

Kahweol decreases hepatic fibrosis by inhibiting the expression of connective tissue growth factor via the transforming growth factor-beta signaling pathway
por: Seo, Hye-Young, et al.
Publicado: (2017)

Extracellular Acidification Augments NLRP3-Mediated Inflammasome Signaling in Macrophages
por: Chae, Byeong Jun, et al.
Publicado: (2023)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan, Zhaofei, et al.
Publicado: (2019)

NLRP12 Inflammasome Expression in the Rat Brain in Response to LPS during Morphine Tolerance
por: Chang, Sulie L., et al.
Publicado: (2017)

SIRT1 Alleviates LPS-Induced IL-1β Production by Suppressing NLRP3 Inflammasome Activation and ROS Production in Trophoblasts
por: Park, Sumi, et al.
Publicado: (2020)

Papaverine Exerts Neuroprotective Effect by Inhibiting NLRP3 Inflammasome Activation in an MPTP-Induced Microglial Priming Mouse Model Challenged with LPS
por: Leem, Yea-Hyun, et al.
Publicado: (2021)

Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
por: Seo, Jung Beom, et al.
Publicado: (2019)

NLRP3 Inflammasome-Mediated Inflammation in Acute Pancreatitis
por: Ferrero-Andrés, Ana, et al.
Publicado: (2020)

The NLRP3 inflammasome: contributions to inflammation-related diseases
por: Chen, Ying, et al.
Publicado: (2023)

Sterile inflammation and the NLRP3 inflammasome in cardiometabolic disease
por: Cho, Sungji, et al.
Publicado: (2023)

Lobeglitazone Exerts Anti-Inflammatory Effect in Lipopolysaccharide-Induced Bone-Marrow Derived Macrophages
por: Jeong, Dabin, et al.
Publicado: (2021)

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia
por: Huang, Ming-Yii, et al.
Publicado: (2018)

Corticosterone Inhibits LPS-Induced NLRP3 Inflammasome Priming in Macrophages by Suppressing Xanthine Oxidase
por: Wu, Ling, et al.
Publicado: (2020)

Cystatin C Deficiency Increases LPS-Induced Sepsis and NLRP3 Inflammasome Activation in Mice
por: Biasizzo, Monika, et al.
Publicado: (2021)

Oridonin Alleviates LPS-Induced Depression by Inhibiting NLRP3 Inflammasome via Activation of Autophagy
por: Li, Chunyan, et al.
Publicado: (2022)

Salmonella Enteritidis GalE Protein Inhibits LPS-Induced NLRP3 Inflammasome Activation
por: Huang, Tingting, et al.
Publicado: (2022)

lncRNA NEAT1 ameliorates LPS-induced inflammation in MG63 cells by activating autophagy and suppressing the NLRP3 inflammasome
por: Dai, Wenyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ddjnbro56pbc9qbls396ml3iue